SPDW - ETF AI Analysis
Top Page
SPDR Portfolio Developed World ex-US ETF (SPDW)
Rating:60Neutral
Price Target:―
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered strong gains so far this year, showing solid momentum in developed markets outside the U.S.
Leading Semiconductor Holdings
Top positions in major chipmakers like Samsung Electronics, ASML, and SK hynix have performed strongly, helping drive the fund’s returns.
Very Low Expense Ratio
The fund charges a very low fee, which helps investors keep more of the returns generated by the portfolio.
Negative Factors
Concentration in a Few Countries
A large portion of the portfolio is focused in Japan and the UK, which can increase the impact of economic or market issues in those countries.
Mixed Performance Among Top Holdings
While several major positions are performing well, some important holdings like AstraZeneca and Nestlé have shown weaker results, slightly offsetting overall strength.
Limited U.S. Market Exposure
Because the ETF specifically excludes most U.S. stocks, investors relying on it alone may miss out on potential gains from the U.S. market and need other funds for full global coverage.
SPDW vs. SPDR S&P 500 ETF (SPY)
AUM39.82B
RegionDeveloped Markets
Expense Ratio0.03%
Beta0.78
IssuerState Street
Inception DateApr 20, 2007
Dividend Yield3.07%
Asset ClassEquity
Index TrackedS&P Developed x United States BMI
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume2,982,928
30 Day Avg. Volume3,310,283
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
56.61Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering2392
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SPDW Summary
SPDW is an ETF that follows the S&P Developed ex-U.S. BMI Index, giving you a simple way to invest in stocks from developed countries outside the United States, such as Japan, the UK, and Europe. It owns hundreds of companies across many industries, including well-known names like Samsung Electronics, Nestlé, and AstraZeneca, so you get broad international diversification in one fund. Investors might consider SPDW to spread their risk beyond the U.S. and tap into long-term global growth. A key risk is that international stock prices can go up and down with global markets and currency changes.
How much will it cost me?The SPDR Portfolio Developed World ex-US ETF (SPDW) has an expense ratio of 0.03%, which means you’ll pay $0.30 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, keeping costs minimal.
What would affect this ETF?SPDW could benefit from global economic growth and technological advancements, especially given its exposure to developed markets and top holdings like ASML and Samsung Electronics. However, it may face challenges from rising interest rates, geopolitical tensions, or sector-specific risks, such as fluctuations in energy prices or regulatory changes in healthcare and financial sectors.
SPDW Top 10 Holdings
SPDW leans heavily on global blue chips, with Samsung and ASML doing much of the heavy lifting as their rising share prices ride the tailwinds in semiconductors and broader tech. Financials are another key engine: HSBC, Royal Bank of Canada, and Mitsubishi UFJ have been steadily climbing, giving the fund a solid banking backbone across Europe, Canada, and Japan. On the flip side, big pharma names like Roche and AstraZeneca have been lagging, and consumer staple giant Nestlé is treading water, slightly dulling the fund’s otherwise broad, developed-markets ex-U.S. story.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Samsung Electronics | 2.51% | $1.00B | $1.13T | 273.98% | ― | |
| ASML Holding NV | 2.12% | $845.77M | €607.20B | 155.85% | 76 Outperform | |
| SK hynix Inc. | 2.03% | $812.71M | ₩10.00T> | 612.06% | ― | |
| HSBC Holdings | 1.06% | $424.78M | £264.80B | 58.91% | 80 Outperform | |
| Royal Bank Of Canada | 0.89% | $355.63M | $294.22B | 57.90% | 75 Outperform | |
| Roche Holding AG | 0.86% | $344.86M | $324.59B | 28.18% | 73 Outperform | |
| Novartis AG | 0.85% | $340.52M | CHF228.82B | 36.49% | 80 Outperform | |
| Nestlé SA | 0.83% | $330.86M | CHF221.65B | 6.80% | 71 Outperform | |
| Mitsubishi UFJ Financial Group | 0.82% | $329.38M | ¥41.02T | 54.86% | 76 Outperform | |
| AstraZeneca | 0.79% | $316.91M | $262.40B | 16.34% | 80 Outperform |
SPDW Technical Analysis
Negative
―
Price Trends
49.89
Negative
48.33
Positive
46.26
Positive
Market Momentum
-0.10
Positive
46.21
Neutral
48.97
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SPDW, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 49.88, equal to the 50-day MA of 49.89, and equal to the 200-day MA of 46.26, indicating a neutral trend. The MACD of -0.10 indicates Positive momentum. The RSI at 46.21 is Neutral, neither overbought nor oversold. The STOCH value of 48.97 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SPDW.
SPDW Peer Comparison
Comparison Results
Performance Comparison
SPDW
SPDR Portfolio Developed World ex-US ETF
49.39
10.04
25.51%
VEA
Vanguard FTSE Developed Markets ETF
―
―
―
SCHF
Schwab International Equity ETF
―
―
―
IDEV
iShares Core MSCI International Developed Markets ETF
―
―
―
AVDE
Avantis International Equity ETF
―
―
―
DFAI
Dimensional International Core Equity Market ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents